In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In a continuation of the US Agency for International Development’s (USAID) focus on global health science and technology, GHTC members PATH and Research!America write about the health and economic benefits of US investments in product development.
In related news, USAID has released new figures detailing how over the past decade, the agency has been involved in more than 1,600 public-private partnerships with more than 3,000 individual entities
The National Institutes of Health published figures detailing how sequestration will impact its 2013 budget. According to the figures, available funds will drop by $1.55 billion from last year.
Aeras received at $2.9 million grant from the Bill & Melinda Gates Foundation to work in collaboration with the University of Oxford and biopharmaceutical company Okairos to support the development of vaccines against tuberculosis, HIV, and malaria.
PATH has launched a clinical trial in Bangladesh to test a new formulation of oral rehydration solution, a therapy to combat severe dehydration resulting from diarrheal disease.